Nasdaq
NKTR
Nektar Therapeutics
- Health Care
- 1 day
- +0.5%
- 1 month
- −1.9%
- 1 year
- +227%
$73.45 · Mkt cap $2.48B
At the 6 Aug 2026 close
Nasdaq
Nektar Therapeutics
$73.45 · Mkt cap $2.48B
At the 6 Aug 2026 close
Nektar Therapeutics trades under the ticker NKTR on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $2.48B. The last closing price was $73.45, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +227%, and −1.9% over the past month. Returns are price returns and exclude dividends.
This page exists because NKTR is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.